Literature DB >> 8167182

Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.

R J Schlemper1, A P van der Maas, J C Eikenboom.   

Abstract

Reports on familial occurrence of essential thrombocythemia (ET) are scanty. Many clinical and hematological aspects of familial ET have not been clarified yet. We studied 16 family members in four successive generations. By laboratory tests and bone marrow examination they were divided into a non-thrombocythemia group (n = 5) and into ET patients (n = 11). Five ET patients were asymptomatic, three patients had both vaso-occlusive and hemorrhagic symptoms, and three patients only vaso-occlusive symptoms. The platelet count ranged from 500 to 1700 x 10(9)/l. Symptoms correlated with age but not with platelet count. ADP-induced platelet aggregation distinguished best between patients and non-ET subjects. Four patients and four non-ET subjects had factor VIII:C or von Willebrand factor antigen abnormalities; all but one had blood group O. These abnormalities were not due to inherited von Willebrand's disease according to haplotype analysis. Two patients and three non-ET subjects had a bleeding diathesis. One of these two patients and all three non-ET subjects had a decreased factor VIII:C or vWF:Ag. No chromosome abnormalities were found. In conclusion, familial ET has a relatively benign course with clinical manifestations similar to nonfamilial cases, and it is probably transmitted by an autosomal dominant mode of inheritance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167182     DOI: 10.1007/bf01727421

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  42 in total

1.  Essential thrombocythemia. Clinical characteristics and course of 61 cases.

Authors:  R Hehlmann; M Jahn; B Baumann; W Köpcke
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

2.  Clinical manifestations of essential thrombocythemia in young adults.

Authors:  F E Millard; C S Hunter; M Anderson; M J Edelman; M P Kosty; G A Luiken; G G Marino
Journal:  Am J Hematol       Date:  1990-01       Impact factor: 10.047

3.  Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.

Authors:  F Fabris; A Casonato; M Grazia del Ben; L De Marco; A Girolami
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

4.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

5.  [Platelet dysfunction in patients with essential thrombocythemia--acquired von Willebrand's disease].

Authors:  H Mohri; H Asada; F Kodama; A Itoh; T Ohkubo
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1986-11

6.  Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients.

Authors:  M Colombi; F Radaelli; L Zocchi; A T Maiolo
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

7.  Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.

Authors:  A Grossi; S Rosseti; A M Vannucchi; D Rafanelli; P R Ferrini
Journal:  Clin Lab Haematol       Date:  1988

8.  Familial myeloproliferative disease. Hematological and cytogenetic studies.

Authors:  P H Slee; J J van Everdingen; J P Geraedts; J te Velde; G J den Ottolander
Journal:  Acta Med Scand       Date:  1981

9.  Acute leukemia as a natural sequel to primary thrombocythemia.

Authors:  S A Geller; E Shapiro
Journal:  Am J Clin Pathol       Date:  1982-03       Impact factor: 2.493

10.  Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.

Authors:  I R Peake; D Bowen; P Bignell; M B Liddell; J E Sadler; G Standen; A L Bloom
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

View more
  4 in total

1.  Clinical utility gene card for: hereditary thrombocythemia.

Authors:  Kais Hussein; Melanie Percy; Mary Frances McMullin; Jiří Schwarz; Susanne Schnittger; Naomi Porret; Luz Maria Martinez-Aviles; Beatriz Bellosillo Paricio; Stéphane Giraudier; Radek Skoda; Eric Lippert; Sylvie Hermouet; Holger Cario
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

2.  Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.

Authors:  Brian J Lannutti; Angela Epp; Jacqueline Roy; Junmei Chen; Neil C Josephson
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

3.  Genetic classification and confirmation of inherited platelet disorders: current status in Korea.

Authors:  Ye Jee Shim
Journal:  Clin Exp Pediatr       Date:  2020-02-06

4.  Thrombocythemia 1 With THPO Variant (c.13+1G>A) Diagnosed Using Targeted Exome Sequencing: First Case in Korea.

Authors:  Nani Jung; Do Hoon Kim; Jung Sook Ha; Ye Jee Shim
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.